Challenges in Developing a Pediatric RSV Vaccine
There is currently no approved respiratory syncytial virus (RSV) vaccine, and the goal of preventing RSV-associated illness in the general population remains unmet. The authors of this article, published in Human Vaccines, discuss the challenges associated with developing a pediatric RSV vaccine and review the potential pediatric RSV vaccine candidates currently under development.
Author(s): Schickli JH, Dubovsky F, Tang RS
Download file (English)
628 KB PDF (Located at www.landesbioscience.com)
Citation: Schickli JH, Dubovsky F, Tang RS. Challenges in Developing a Pediatric RSV Vaccine. Human Vaccines. 2009;5(9):582-591.